Safety/Biomarker Study of CNTO 95 and Avastin in Solid Tumors (CNTO95/Avastin)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Centocor, Inc.
Genentech, Inc.
Information provided by (Responsible Party):
Herbert Hurwitz, MD, Duke University Medical Center
ClinicalTrials.gov Identifier:
NCT00888043
First received: April 23, 2009
Last updated: May 13, 2014
Last verified: May 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2014
  Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)